John D. Ulm

Array ( [id] => 3991848 [patent_doc_number] => 05985599 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'FC receptor for immunoglobulin' [patent_app_type] => 1 [patent_app_number] => 8/332562 [patent_app_country] => US [patent_app_date] => 1994-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 37 [patent_no_of_words] => 43311 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985599.pdf [firstpage_image] =>[orig_patent_app_number] => 332562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725591 [patent_doc_number] => 05670319 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Assay for tumor necrosis factor receptor-associated factors' [patent_app_type] => 1 [patent_app_number] => 8/331394 [patent_app_country] => US [patent_app_date] => 1994-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 23 [patent_no_of_words] => 33640 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670319.pdf [firstpage_image] =>[orig_patent_app_number] => 331394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3627408 [patent_doc_number] => 05621077 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Soluble IFN-.beta.2/IL-6 binding protein its preparation, and pharmaceutical compositions containing it' [patent_app_type] => 1 [patent_app_number] => 8/329785 [patent_app_country] => US [patent_app_date] => 1994-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8667 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/621/05621077.pdf [firstpage_image] =>[orig_patent_app_number] => 329785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4100131 [patent_doc_number] => 06100042 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/322137 [patent_app_country] => US [patent_app_date] => 1994-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 11 [patent_no_of_words] => 60282 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100042.pdf [firstpage_image] =>[orig_patent_app_number] => 322137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622622 [patent_doc_number] => 05607843 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Nucleic acid sequence encoding apamin binding protein' [patent_app_type] => 1 [patent_app_number] => 8/314979 [patent_app_country] => US [patent_app_date] => 1994-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 5925 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/607/05607843.pdf [firstpage_image] =>[orig_patent_app_number] => 314979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1326432 [patent_doc_number] => 06602983 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'Polypeptide and DNA sequence corresponding to human receptor with high affinity for IgE' [patent_app_type] => B1 [patent_app_number] => 08/310902 [patent_app_country] => US [patent_app_date] => 1994-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3735 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602983.pdf [firstpage_image] =>[orig_patent_app_number] => 08310902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685891 [patent_doc_number] => 05643748 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'HU-B1.219, a novel human hematopoietin receptor' [patent_app_type] => 1 [patent_app_number] => 8/306231 [patent_app_country] => US [patent_app_date] => 1994-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 9842 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643748.pdf [firstpage_image] =>[orig_patent_app_number] => 306231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3768680 [patent_doc_number] => 05756307 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Sequence of human dopamine transporter cDNA' [patent_app_type] => 1 [patent_app_number] => 8/301722 [patent_app_country] => US [patent_app_date] => 1994-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 12063 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756307.pdf [firstpage_image] =>[orig_patent_app_number] => 301722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3590369 [patent_doc_number] => 05516894 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-14 [patent_title] => 'A.sub.2b -adenosine receptors' [patent_app_type] => 1 [patent_app_number] => 8/293563 [patent_app_country] => US [patent_app_date] => 1994-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 11639 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/516/05516894.pdf [firstpage_image] =>[orig_patent_app_number] => 293563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3115004 [patent_doc_number] => 05464938 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-07 [patent_title] => 'Isolated viral protein TNF antagonists' [patent_app_type] => 1 [patent_app_number] => 8/292549 [patent_app_country] => US [patent_app_date] => 1994-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12425 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/464/05464938.pdf [firstpage_image] =>[orig_patent_app_number] => 292549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3700891 [patent_doc_number] => 05674753 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Epidermal growth factor receptor ectodomain' [patent_app_type] => 1 [patent_app_number] => 8/288481 [patent_app_country] => US [patent_app_date] => 1994-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14575 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674753.pdf [firstpage_image] =>[orig_patent_app_number] => 288481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3488044 [patent_doc_number] => 05470730 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-28 [patent_title] => 'Method for producing T.sub.H -independent cytotoxic T lymphocytes' [patent_app_type] => 1 [patent_app_number] => 8/287111 [patent_app_country] => US [patent_app_date] => 1994-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14409 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/470/05470730.pdf [firstpage_image] =>[orig_patent_app_number] => 287111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3655720 [patent_doc_number] => 05622861 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Recombinant DNA encoding hepatitis A virus receptor' [patent_app_type] => 1 [patent_app_number] => 8/287001 [patent_app_country] => US [patent_app_date] => 1994-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12153 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622861.pdf [firstpage_image] =>[orig_patent_app_number] => 287001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3646211 [patent_doc_number] => 05629172 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Expression of fusion polypeptides transported out of the cytoplasm without leader sequences' [patent_app_type] => 1 [patent_app_number] => 8/284784 [patent_app_country] => US [patent_app_date] => 1994-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 78 [patent_no_of_words] => 20214 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/629/05629172.pdf [firstpage_image] =>[orig_patent_app_number] => 284784 [rel_patent_id] =>[rel_patent_doc_number] =>)